Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mRNA Vaccination”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Not applicableUnknownNCT04961502
What this trial is testing

Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions

Who this might be right for
Elderly People Institutionalized in Long-term Care Services
Gérond'if 80
Not applicableUnknownNCT05079165
What this trial is testing

Covid Vaccination in Liver Transplantation

Who this might be right for
COVID-19
University Hospital, Strasbourg, France 300
Early research (Phase 1)Study completedNCT05260437
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 99
Not applicableUnknownNCT05175989
What this trial is testing

SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19

Who this might be right for
COVID-19 Vaccine
Rabin Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT01530698
What this trial is testing

Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT05650554
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 682
Early research (Phase 1)UnknownNCT05433194
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 48
Early research (Phase 1)WithdrawnNCT05609045
What this trial is testing

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

Who this might be right for
COVID-19 Pandemic
Wuhan Rhegen Biotechnology Co., Ltd.
Large-scale testing (Phase 3)UnknownNCT05124171
What this trial is testing

Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination

Who this might be right for
COVID-19Vaccine Reaction
Assistance Publique - Hôpitaux de Paris 247
Early research (Phase 1)Study completedNCT05829356
What this trial is testing

Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 159
Testing effectiveness (Phase 2)Study completedNCT05463354
What this trial is testing

Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd. 410
Not applicableStudy completedNCT05308680
What this trial is testing

Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose Vaccination Among Israeli Health Care Workers

Who this might be right for
Myocardial InjuryVaccine Adverse ReactionCOVID-19
Shaare Zedek Medical Center 336
Early research (Phase 1)Study completedNCT05305300
What this trial is testing

A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals

Who this might be right for
COVID-19 Pandemic
Yisheng Biopharma (Singapore) Pte. Ltd. 135
Testing effectiveness (Phase 2)Ended earlyNCT05977127
What this trial is testing

Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly

Who this might be right for
Vaccination; InfectionCOVID-19
Radboud University Medical Center 48
Post-approval studies (Phase 4)Active Not RecruitingNCT07051031
What this trial is testing

COVID-19 Reactogenicity

Who this might be right for
COVID-19
Marcel Curlin 1,000
Not applicableUnknownNCT05055531
What this trial is testing

"Effects of the Vaccin Against COVID 19 in a Cohort of Dialysis Patients: Adverse Events and Immunological Response"

Who this might be right for
COVID Epidemic
Raincy Montfermeil Hospital Group 60
Not applicableStudy completedNCT05894525
What this trial is testing

Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 8,844
Not applicableStudy completedNCT05359250
What this trial is testing

Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

Who this might be right for
Myocardial InjuryCOVID-19Vaccine Reaction
University of Colorado, Denver 10
Testing effectiveness (Phase 2)Study completedNCT05624606
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 682
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Next Page